Samyadev Datta MD, FRCA

Dr. Samyadev Datta, the director, is a nationally and internationally known double board-certified pain specialist and anesthesiologist. He is also a Fellow of the Royal College of Anesthesiologists of England. His expertise is grounded in over 30 years of helping patients in pain from all walks of life. His post-doctoral training includes positions in England and at Columbia Presbyterian Medical Center in New York. He completed his fellowship in pain management at Memorial Sloan-Kettering Cancer Center. He is one of the most qualified and highly trained pain management physicians in the tri-state area.

He was on staff at Memorial Sloan-Kettering and Cornell Weill Medical College for many years where he refined his skills in treating complex cancer pain patients. He was actively involved in the fellowship training program.

It is a testament to Dr. Datta’s skills that all his patients are referred via colleagues and they are willing to travel from other states to see him. It is truly a testament to his skill and compassion, that even after 25 years he continues to enjoy their confidence and continued support. They have always referred to the most complicated cases.

These patients are often seeking non-surgical pain relief. He is available for an evaluation, a consultation, advanced treatment, or a second opinion.

Over the years he has been named Top Anesthesiologist and Pain Management doctor by various organizations, every year by Castle Connelly, New Yorker, and NJ Monthly since 2012. A respected expert in pain management, he offers seminars to other physicians on pain management and lectures extensively on pain treatments. He has published numerous articles including on neurolytic techniques for cancer pain management, chronic pain syndromes, and ethical dilemmas in pain management. He has contributed chapters to multiple books. In 2015 “Practical management of complex cancer pain” from Oxford University Press was named BMA Medical Book of the year 2015 as well as first prize in the oncology category.

He is involved in research trials. Presently he is the only center involved in the MOTION trial in New Jersey. This is a long-term trial on the efficacy of minimally invasive lumbar decompression. (MILD).

He is also highly skilled and experienced in managing patients with intrathecal pumps (morphine pumps). Presently they manage the largest number of pumps in New Jersey.

He is very passionate about the treatment of complex regional pain syndrome and has been using new and innovative therapy in the treatment including ketamine infusion, of which they have done more than 8000 infusions in the last 12 years. Over the last 10 years, he has had extensive experience in the use of low-dose naltrexone. This is an opioid antagonist that provides pain relief, especially for various neuropathic pain conditions. It has allowed us to wean many patients off opioids, contributing to reducing the burden of opioids in society.